RET c.2524_2525delinsAT ;(p.D842I)

Variant ID: 10-43615110-GA-AT

NM_020975.4(RET):c.2524_2525delinsAT;(p.D842I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.

Nature Cancer
Tamborero, David D; Dienstmann, Rodrigo R; Rachid, Maan Haj MH; Boekel, Jorrit J; Lopez-Fernandez, Adria A; Jonsson, Markus M; Razzak, Ali A; Braña, Irene I; De Petris, Luigi L; Yachnin, Jeffrey J; Baird, Richard D RD; Loriot, Yohann Y; Massard, Christophe C; Martin-Romano, Patricia P; Opdam, Frans F; Schlenk, Richard F RF; Vernieri, Claudio C; Masucci, Michele M; Villalobos, Xenia X; Chavarria, Elena E; , ; Balmaña, Judith J; Apolone, Giovanni G; Caldas, Carlos C; Bergh, Jonas J; Ernberg, Ingemar I; Fröhling, Stefan S; Garralda, Elena E; Karlsson, Claes C; Tabernero, Josep J; Voest, Emile E; Rodon, Jordi J; Lehtiö, Janne J
Publication Date: 2022-02

Variant appearance in text: RET: Asp842Ile
PubMed Link: 35221333
Variant Present in the following documents:
  • 43018_2022_332_MOESM3_ESM.xlsx, sheet 1
View BVdb publication page



Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies.

International Journal Of Molecular Sciences
Hojjat-Farsangi, Mohammad M
Publication Date: 2014-08-08

Variant appearance in text: RET: D842I
PubMed Link: 25110867
Variant Present in the following documents:
  • Main text
View BVdb publication page